12th Edition of International Conference on Neurology and Brain Disorders
October 20-22, 2025
Rare and Complex Brain Disorders
Rare and complex brain disorders present unique challenges for clinicians and researchers due to their heterogeneous nature and the limited understanding of their underlying mechanisms. These disorders, including conditions like cortical dysplasia, rare forms of epilepsy, and neurodegenerative diseases, often require specialized care and treatment plans tailored to the specific needs of each patient. Despite their rarity, the impact of these disorders on patients and their families can be profound, leading to significant physical, cognitive, and emotional challenges. Advances in research are beginning to unravel the genetic and molecular foundations of these conditions, offering hope for the development of more effective therapies. Early detection, better diagnostic tools, and innovative treatments, such as gene therapy and neurostimulation, are paving the way for improved outcomes and quality of life for individuals with rare brain disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
Thomas J Webster
Interstellar Therapeutics, United States
Roger H Coletti
Interventional Health, PA, United States
Stephen Grossberg
Boston University, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Krishna Moorjani, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Abhay Murthy, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signalling
Ethan Liu, Boston University, United States